TITLE

Predictive value of arterial ammonia for complications and outcome in acute liver failure

AUTHOR(S)
Bhatia, V.; Singh, R.; Acharya, S. K.
PUB. DATE
January 2006
SOURCE
Gut;Jan2006, Vol. 55 Issue 1, p98
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aim: In acute liver failure (ALF), the brain is exposed to high levels of ammonia. Human studies defining the clinical significance of ammonia in ALF are lacking. This prospective study evaluated the relationship of arterial ammonia levels at admission to complications and survival among patients with ALF. Methods: Eighty consecutive ALF patients admitted from March 2001 to December 2003 were followed up until death or complete recovery. All had arterial ammonia estimation at admission (enzymatic method). Logistic regression analysis was performed to identify independent predictors of mortality. Results: Forty two (52.5%) patients died. Non-survivors had significantly higher median ammonia levels than survivors (174.7 v 105.0 μmol/l; p<0.001). An arterial ammonia level of ⩾ 124 μmol/l was found to predict mortality with 78.6% sensitivity and 76.3% specificity, and had 77.5% diagnostic accuracy. Patients with higher ammonia levels also developed more complications, including deeper encephalopathy (p=0.055), cerebral oedema (p=0.020), need for ventilation (p<0.001), and seizures (p=0.006). Logistic regression analysis showed that pH, presence of cerebral oedema, and arterial ammonia at admission were independent predictors of mortality (odds ratios 6.6, 12.6, and 10.9, respectively). Incorporating these variables, a score predicting mortality risk at admission was derived: 2.53 + 2.91 ammonia + 2.41 oedema + 1.40 pH, where ammonia is scored as 0 (if <124 μmol/l) or 1 (if ⩾124 μmol/l); oedema is scored as 0 (absent) or 1 (present); and pH is scored as 1 (if ⩽7.40) or 0 (if >7.40). Levels of partial pressure of ammonia were equally correlated with outcome. Conclusion: Arterial ammonia at presentation is predictive of outcome and can be used for risk stratification. Ammonia lowering therapies in patients with ALF should be evaluated.
ACCESSION #
19623590

 

Related Articles

  • Management of acute liver failure. Wai Kwan Lai; Murphy, Nick // Continuing Education in Anaesthesia, Critical Care & Pain;Apr2004, Vol. 4 Issue 2, p40 

    Acute liver failure (ALF) is a devastating syndrome that triggers a cascade of events, leading to multiple organ failure and often death. A previously normal liver may fail within days or weeks; and despite recent advances in intensive care and organ support, mortality rates remain high. In...

  • Value of the Apparent Diffusion Coefficient for Quantification of Low-Grade Hepatic Encephalopathy. Sugimoto, Ryosuke; Iwasa, Motoh; Maeda, Masayuki; Urawa, Naohito; Tanaka, Hideaki; Fujita, Naoki; Kobayashi, Yoshinao; Takeda, Kan; Kaito, Masahiko; Takei, Yoshiyuki // American Journal of Gastroenterology;Jun2008, Vol. 103 Issue 6, p1413 

    BACKGROUND AND AIMS: Minimal hepatic encephalopathy (HE) is associated with poorer quality of life and increased work disability. Recently, low-grade cerebral edema has been implicated in chronic liver disease. METHODS: We measured the apparent diffusion coefficient (ADC) of water in various...

  • The Na–K–Cl Co-transporter in astrocyte swelling. Jayakumar, Arumugam R.; Norenberg, Michael D. // Metabolic Brain Disease;Mar2010, Vol. 25 Issue 1, p31 

    Ion channels, exchangers and transporters are known to be involved in cell volume regulation. A disturbance in one or more of these systems may result in loss of ion homeostasis and cell swelling. In particular, activation of the Na+–K+–Cl− cotransporters has been shown to...

  • Management of Hepatic Encephalopathy. Wright, G.; Chattree, A.; Jalan, R. // International Journal of Hepatology;2011, p1 

    Hepatic encephalopathy (HE), the neuropsychiatric presentation of liver disease, is associated with high morbidity and mortality. Reduction of plasma ammonia remains the central therapeutic strategy, but there is a need for newer novel therapies. We discuss current evidence supporting the use of...

  • FALLA HEPÁTICA FULMINANTE. VELASCO-BENÍTEZ, CARLOS ALBERTO // Revista Gastrohnup;2012 supplement 1, Vol. 14, pS4 

    The term fulminant hepatic failure refers to the failure of vital functions liver a few weeks or a few months after a liver disease that is clinically expressed. Depending on the pediatric age group, the etiology may vary. Protective factors have been described as an early time of admission, the...

  • The brain in acute on chronic liver failure. Wright, Gavin; Sharifi, Yalda; Jover-Cobos, Maria; Jalan, Rajiv // Metabolic Brain Disease;Dec2014, Vol. 29 Issue 4, p965 

    Acute-on-chronic liver failure (ACLF) is a newly defined clinical entity with significant morbidity and mortality (~40-90 % at 1 year dependent on need for organ support at presentation). It defines a presentation with acute severe liver injury, often with multiorgan dysfunction, on a background...

  • Magnetic resonance of the brain in chronic and acute liver failure. Chavarria, Laia; Cordoba, Juan // Metabolic Brain Disease;Dec2014, Vol. 29 Issue 4, p937 

    Brain alterations such as hepatic encephalopathy or brain edema are usually associated with liver failure. The mechanisms that lead to the generation of edema seem to be different depending on the course of liver failure (acute, chronic or acute-on-chronic liver failure). Several neuroimaging...

  • Pathogenesis of Hepatic Encephalopathy and Brain Edema in Acute Liver Failure. Butterworth, Roger F. // Experimental & Clinical Hepatology;Mar2015, Vol. 5 Issue S1, pS96 

    Neuropathologic investigations in acute liver failure (ALF) reveal significant alterations to neuroglia consisting of swelling of astrocytes leading to cytotoxic brain edema and intracranial hypertension as well as activation of microglia indicative of a central neuroinflammatory response....

  • Management in Acute Liver Failure. Shalimar; Acharya, Subrat K. // Experimental & Clinical Hepatology;Mar2015, Vol. 5 Issue S1, pS104 

    Acute liver failure (ALF) is a rare, potentially fatal complication of severe hepatic illness resulting from various causes. In a clinical setting, severe hepatic injury is usually recognised by the appearance of jaundice, encephalopathy and coagulopathy. The central and most important clinical...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics